MDC — Medlab Clinical Cashflow Statement
0.000.00%
HealthcareAdventurousMicro Cap
Annual cashflow statement for Medlab Clinical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 2.45 | 3.39 | 3.42 | 3.74 | 2.74 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -10.4 | -10.4 | -9.27 | -5.47 | -0.166 |
Capital Expenditures | -0.243 | -0.083 | -0.029 | -0.016 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | 0 | 1.78 | 0.999 | 0.05 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.243 | -0.083 | 1.75 | 0.983 | 0.05 |
Financing Cash Flow Items | -0.563 | -1.12 | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 8.32 | 14.8 | -0.725 | -0.482 | 0 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2.38 | 4.37 | -8.24 | -4.97 | -0.116 |